The report on the global preclinical imaging market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global preclinical imaging market to grow with a CAGR of 5.3% over the forecast period from 2019-2025. The study on preclinical imaging market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on preclinical imaging market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global preclinical imaging market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global preclinical imaging market over the period of 2017 to 2025. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers

  • Growth in the prevalence of chronic diseases

2) Restraints

  • High operation and Installation cost associated with it

3) Opportunities

  • Growing research infrastructure

Research methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global preclinical imaging market is segmented on the basis of product, application, and end-user.

The Global Preclinical Imaging Market by Product

  • Modalities
  • ·Magnetic Resonance Imaging
  • ·Single-photon Emission Computed Tomography
  • ·Micro-computed Tomography
  • ·Positron Emission Tomography
  • ·Magnetic Particle Imaging
  • ·Optical Imaging
  • Reagents
  • ·Bioluminescent Imaging Reagents
  • ·Fluorescent Imaging Reagents
  • ·PET Radioactive Tracers
  • ·X-ray CT Contrasting Reagents
  • · MRI Contrasting Reagents
  • ·Ultrasound Contrasting Reagents

The Global Preclinical Imaging Market by Application

  • Research and Development
  • Drug Discovery

The Global Preclinical Imaging Market by End-user

  • Pharmaceutical Companies
  • Biotech Companies
  • Research Institutes

Company Profiles
The companies covered in the report include

  • MR Solutions
  • TriFoil Imaging
  • Bruker Corporation
  • PerkinElmer Inc
  • FUJIFILM Holdings America Corporation
  • Mediso Ltd
  • Miltenyi Biotec
  • Aspect Imaging
  • Li-Cor Biosciences
  • MILabs B.V

What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the preclinical imaging market.
2. Complete coverage of all the segments in the preclinical imaging market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global preclinical imaging market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.